Close Menu

stock rating

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Investment firm Mizuho Securities has initiated coverage of Complete Genomics with an Outperform rating and a 12-month price target of $10.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – William Blair initiated coverage of Sequenom today with an Outperform rating, citing the commercial potential of the San Diego-based company's T21 molecular diagnostics test.

While a number of analysts maintained prior ratings on Exact Sciences, Rodman & Renshaw downgraded the company to Perform from Outperform.

The analyst said that the launch of GTG's BrevaGen test in the US in June is expected to "add significantly to revenues from FY 13 and profit in FY 14."

Several analysts lowered EPS, revenue, and price target estimates for Life Tech, though one analyst cited a bright note on the company's Ion Torrent business.

Analyst Amit Bhalla said that trade-in revenue from customers who purchase the HiSeq 2000 platform would not be a "significant contributor," and trimmed total revenue estimates for the second quarter and full-year 2011.

Pages

The founder of MeTooSTEM, BethAnn McLaughlin, created a Twitter account purported to be that of an LGBTQ Native American professor at Arizona State University, the New York Times writes.

Novavax reports its candidate SARS-CoV-2 vaccine leads to immune responses, according to the Sydney Morning Herald.

Gene length is associated with lifespan in a comparative genomics study appearing in the Proceedings of the National Academy of Sciences that draws on the whale shark genome.

In Nucleic Acids Research this week: effort to annotate the rat transcriptome, web-based resource to characterize marine microbes, and more.